Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Goodwill & Intangibles (2010 - 2026)

Emergent BioSolutions (EBS) posted Goodwill & Intangibles of $261.8 million for Q2 2026, down 44.35% on a QoQ basis from $470.4 million in Q1 2026, and down 44.18% year-over-year from $469.0 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Goodwill & Intangibles (2010 - 2026) Analysis & Trends

Emergent BioSolutions has reported Goodwill & Intangibles for 17 years, with the latest figure at $261.8 million in Q2 2026.

  • On a quarterly basis, Goodwill & Intangibles fell 44.18% year-over-year to $261.8 million in Q2 2026; TTM through Jun 2026 was $261.8 million, a 44.18% decrease from a year earlier, with the FY2025 full-year figure at $436.5 million, down 12.96% from the prior year.
  • Goodwill & Intangibles was $261.8 million for Q2 2026 at Emergent BioSolutions, down from $470.4 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $949.8 million in Q3 2022, with the low at $261.8 million in Q2 2026.
  • Average Goodwill & Intangibles over 5 years is $610.0 million, with a median of $542.2 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Goodwill & Intangibles climbed 14.17% in 2022, then plunged 44.18% in 2026.
  • Over 5 years, Goodwill & Intangibles stood at $947.0 million in 2022, then sank by 40.17% to $566.6 million in 2023, then fell by 11.49% to $501.5 million in 2024, then retreated by 12.96% to $436.5 million in 2025, then sank by 40.02% to $261.8 million in 2026.
  • The last three Goodwill & Intangibles figures came in at $261.8 million (Q2 2026), $470.4 million (Q1 2026), and $436.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn
9 Revolution Medicines 41.30 Bn 41.30 Bn -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 261.80 Mn
Mar 31, 2026 470.40 Mn
Dec 31, 2025 436.50 Mn
Sep 30, 2025 452.70 Mn
Jun 30, 2025 469.00 Mn
Mar 31, 2025 485.20 Mn
Dec 31, 2024 501.50 Mn
Sep 30, 2024 517.80 Mn
Jun 30, 2024 534.10 Mn
Mar 31, 2024 550.40 Mn
Dec 31, 2023 566.60 Mn
Sep 30, 2023 582.80 Mn
Jun 30, 2023 811.00 Mn
Mar 31, 2023 827.10 Mn
Dec 31, 2022 947.00 Mn
Sep 30, 2022 949.80 Mn
Jun 30, 2022 801.50 Mn
Mar 31, 2022 815.50 Mn
Dec 31, 2021 829.50 Mn
Sep 30, 2021 885.10 Mn
API Access

Emergent BioSolutions Goodwill & Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=EBS&period=max&api_key=YOUR_API_KEY